This report covers market size and forecasts of Drug of Abuse (DOA) Testing Equipment, including the following market information:
Global Drug of Abuse (DOA) Testing Equipment Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Drug of Abuse (DOA) Testing Equipment Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Drug of Abuse (DOA) Testing Equipment Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Drug of Abuse (DOA) Testing Equipment Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Key market players
Major competitors identified in this market include Siemens AG, Merck, Roche, Thermo Fisher Scientific, Bio-Rad, Abbott, Quest Diagnostics, Express Diagnostics Int'l, Psychemedics, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Immunoassay analyzers
Chromatography instruments
Breath analyzers
Others
Based on the Application:
Hospitals
Laboratories
Workplace
At-Home
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Drug of Abuse (DOA) Testing Equipment Industry
1.7 COVID-19 Impact: Drug of Abuse (DOA) Testing Equipment Market Trends
2 Global Drug of Abuse (DOA) Testing Equipment Quarterly Market Size Analysis
2.1 Drug of Abuse (DOA) Testing Equipment Business Impact Assessment - COVID-19
2.1.1 Global Drug of Abuse (DOA) Testing Equipment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Drug of Abuse (DOA) Testing Equipment Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Drug of Abuse (DOA) Testing Equipment Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Drug of Abuse (DOA) Testing Equipment Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Drug of Abuse (DOA) Testing Equipment Factory Price by Manufacturers
3.3 Location of Key Manufacturers Drug of Abuse (DOA) Testing Equipment Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Drug of Abuse (DOA) Testing Equipment Market
3.5 Key Manufacturers Drug of Abuse (DOA) Testing Equipment Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Drug of Abuse (DOA) Testing Equipment Segments, By Type
4.1 Introduction
1.4.1 Immunoassay analyzers
1.4.2 Chromatography instruments
1.4.3 Breath analyzers
1.4.4 Others
4.2 By Type, Global Drug of Abuse (DOA) Testing Equipment Market Size, 2019-2021
4.2.1 By Type, Global Drug of Abuse (DOA) Testing Equipment Market Size by Type, 2020-2021
4.2.2 By Type, Global Drug of Abuse (DOA) Testing Equipment Price, 2020-2021
5 Impact of Covid-19 on Drug of Abuse (DOA) Testing Equipment Segments, By Application
5.1 Overview
5.5.1 Hospitals
5.5.2 Laboratories
5.5.3 Workplace
5.5.4 At-Home
5.2 By Application, Global Drug of Abuse (DOA) Testing Equipment Market Size, 2019-2021
5.2.1 By Application, Global Drug of Abuse (DOA) Testing Equipment Market Size by Application, 2019-2021
5.2.2 By Application, Global Drug of Abuse (DOA) Testing Equipment Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Siemens AG
7.1.1 Siemens AG Business Overview
7.1.2 Siemens AG Drug of Abuse (DOA) Testing Equipment Quarterly Production and Revenue, 2020
7.1.3 Siemens AG Drug of Abuse (DOA) Testing Equipment Product Introduction
7.1.4 Siemens AG Response to COVID-19 and Related Developments
7.2 Merck
7.2.1 Merck Business Overview
7.2.2 Merck Drug of Abuse (DOA) Testing Equipment Quarterly Production and Revenue, 2020
7.2.3 Merck Drug of Abuse (DOA) Testing Equipment Product Introduction
7.2.4 Merck Response to COVID-19 and Related Developments
7.3 Roche
7.3.1 Roche Business Overview
7.3.2 Roche Drug of Abuse (DOA) Testing Equipment Quarterly Production and Revenue, 2020
7.3.3 Roche Drug of Abuse (DOA) Testing Equipment Product Introduction
7.3.4 Roche Response to COVID-19 and Related Developments
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Business Overview
7.4.2 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Equipment Quarterly Production and Revenue, 2020
7.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Equipment Product Introduction
7.4.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
7.5 Bio-Rad
7.5.1 Bio-Rad Business Overview
7.5.2 Bio-Rad Drug of Abuse (DOA) Testing Equipment Quarterly Production and Revenue, 2020
7.5.3 Bio-Rad Drug of Abuse (DOA) Testing Equipment Product Introduction
7.5.4 Bio-Rad Response to COVID-19 and Related Developments
7.6 Abbott
7.6.1 Abbott Business Overview
7.6.2 Abbott Drug of Abuse (DOA) Testing Equipment Quarterly Production and Revenue, 2020
7.6.3 Abbott Drug of Abuse (DOA) Testing Equipment Product Introduction
7.6.4 Abbott Response to COVID-19 and Related Developments
7.7 Quest Diagnostics
7.7.1 Quest Diagnostics Business Overview
7.7.2 Quest Diagnostics Drug of Abuse (DOA) Testing Equipment Quarterly Production and Revenue, 2020
7.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Equipment Product Introduction
7.7.4 Quest Diagnostics Response to COVID-19 and Related Developments
7.8 Express Diagnostics Int'l
7.8.1 Express Diagnostics Int'l Business Overview
7.8.2 Express Diagnostics Int'l Drug of Abuse (DOA) Testing Equipment Quarterly Production and Revenue, 2020
7.8.3 Express Diagnostics Int'l Drug of Abuse (DOA) Testing Equipment Product Introduction
7.8.4 Express Diagnostics Int'l Response to COVID-19 and Related Developments
7.9 Psychemedics
7.9.1 Psychemedics Business Overview
7.9.2 Psychemedics Drug of Abuse (DOA) Testing Equipment Quarterly Production and Revenue, 2020
7.9.3 Psychemedics Drug of Abuse (DOA) Testing Equipment Product Introduction
7.9.4 Psychemedics Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Drug of Abuse (DOA) Testing Equipment Supply Chain Analysis
8.1.1 Drug of Abuse (DOA) Testing Equipment Supply Chain Analysis
8.1.2 Covid-19 Impact on Drug of Abuse (DOA) Testing Equipment Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Drug of Abuse (DOA) Testing Equipment Distribution Channels
8.2.2 Covid-19 Impact on Drug of Abuse (DOA) Testing Equipment Distribution Channels
8.2.3 Drug of Abuse (DOA) Testing Equipment Distributors
8.3 Drug of Abuse (DOA) Testing Equipment Customers
Summary: Get latest Market Research Reports on Drug of Abuse (DOA) Testing Equipment . Industry analysis & Market Report on Drug of Abuse (DOA) Testing Equipment is a syndicated market report, published as Global Drug of Abuse (DOA) Testing Equipment Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Drug of Abuse (DOA) Testing Equipment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.